Brent Allan

Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)

Messoud Ashina, Joel R. Saper, Roger Cady et al. · Cephalalgia · 2020 · 397 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Efficacy and safety of eptinezumab in patients with chronic migraine

Richard B. Lipton, Peter J. Goadsby, Jeff Smith et al. · Neurology · 2020 · 392 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Community-level changes in condom use and uptake of HIV pre-exposure prophylaxis by gay and bisexual men in Melbourne and Sydney, Australia: results of repeated behavioural surveillance in 2013–17

Martin Holt, Toby Lea, Limin Mao et al. · The Lancet HIV · 2018 · 182 citations · Full text

Public Health, Community Health, Preventive Medicine +17

Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries

Chinyere Okoli, Nicolas Van de Velde, Bruce W. Richman et al. · Sexually Transmitted Infections · 2020 · 156 citations · Full text

Public Health, Health Promotion, Public Health Practice +17

Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study

Stephen D. Silberstein, Merle L. Diamond, Nada Hindiyeh et al. · The Journal of Headache and Pain · 2020 · 103 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15